|
Risk Factors
Citations 451-460 of 1542 total displayed.
|
Past content
(since Jan 1999):
|
- Issue Highlights
Issue Highlights
-
Circulation 2006;114:359
[Full text]
- Clinician Update
Intravascular Ultrasound in Cardiovascular Medicine
- Stephen J. Nicholls, E. Murat Tuzcu, Ilke Sipahi, Paul Schoenhagen, and Steven E. Nissen
Circulation 2006;114:e55-59e, doi:10.1161/CIRCULATIONAHA.106.637942
[Full text]
- Correspondence
Letter by Powers et al Regarding Article, "Riboflavin Lowers Homocysteine in Individuals Homozygous for the MTHFR 677C T Polymorphism"
- Hilary J. Powers, Ian F.W. McDowell, and Stuart J. Moat
Circulation 2006;114:e65, doi:10.1161/CIRCULATIONAHA.106.613299
[Full text]
- Coronary Heart Disease
Clinical Relevance of C-Reactive Protein During Follow-Up of Patients With Acute Coronary Syndromes in the Aggrastat-to-Zocor Trial
- David A. Morrow, James A. de Lemos, Marc S. Sabatine, Stephen D. Wiviott, Michael A. Blazing, Amy Shui, Nader Rifai, Robert M. Califf, and Eugene Braunwald
Circulation 2006;114:281-288; published online before print as doi:10.1161/CIRCULATIONAHA.106.628909
[Abstract]
[Full text]
- Editorials
Risk Stratification in Secondary Prevention: Advances in Multimarker Profiles, or Back to Basics?
- Caroline Kistorp
Circulation 2006;114:184-186, doi:10.1161/CIRCULATIONAHA.106.639732
[Full text]
- Epidemiology
Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study
- Stefan Blankenberg, Matthew J. McQueen, Marek Smieja, Janice Pogue, Cynthia Balion, Eva Lonn, Hans J. Rupprecht, Christoph Bickel, Laurence Tiret, Francois Cambien, Hertzel Gerstein, Thomas Münzel, Salim Yusuf for the HOPE Study Investigators
Circulation 2006;114:201-208; published online before print as doi:10.1161/CIRCULATIONAHA.105.590927
[Abstract]
[Full text]
- Vascular Medicine
Physical Activity During Daily Life and Mortality in Patients With Peripheral Arterial Disease
- Parveen K. Garg, Lu Tian, Michael H. Criqui, Kiang Liu, Luigi Ferrucci, Jack M. Guralnik, Jin Tan, and Mary M. McDermott
Circulation 2006;114:242-248; published online before print as doi:10.1161/CIRCULATIONAHA.105.605246
[Abstract]
[Full text]
- Articles
Clinical Relevance of C-Reactive Protein During Follow-Up of Patients With Acute Coronary Syndromes in the Aggrastat-to-Zocor Trial
- David A. Morrow, James A. de Lemos, Marc S. Sabatine, Stephen D. Wiviott, Michael A. Blazing, Amy Shui, Nader Rifai, Robert M. Califf, and Eugene Braunwald
Circulation published July 17, 2006, doi:10.1161/CIRCULATIONAHA.106.628909
[Abstract]
- Preventive Cardiology
Healthy Lifestyle Factors in the Primary Prevention of Coronary Heart Disease Among Men: Benefits Among Users and Nonusers of Lipid-Lowering and Antihypertensive Medications
- Stephanie E. Chiuve, Marjorie L. McCullough, Frank M. Sacks, and Eric B. Rimm
Circulation 2006;114:160-167; published online before print as doi:10.1161/CIRCULATIONAHA.106.621417
[Abstract]
[Full text]
- Articles
Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study
- Stefan Blankenberg, Matthew J. McQueen, Marek Smieja, Janice Pogue, Cynthia Balion, Eva Lonn, Hans J. Rupprecht, Christoph Bickel, Laurence Tiret, Francois Cambien, Hertzel Gerstein, Thomas Münzel, Salim Yusuf for the HOPE Study Investigators
Circulation published July 10, 2006, doi:10.1161/CIRCULATIONAHA.105.590927
[Abstract]
|
|
